期刊文献+

Ang-2、VEGF及VEGFR3在喉鳞癌中的表达及其临床意义

Expression of Ang-2,VEGF and VEGFR-3 in Larynx Squamous Cell Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的研究喉鳞癌组织中促血管生成素-2(Angiopoietin-2,Ang-2)、血管内皮生长因子(vascular endothelial growth factor,VEGF)及受体-3(VEGFR-3)的表达及其与临床病理学特征间的关系。方法采用免疫组织化学方法检测喉鳞癌患者癌组织及癌旁正常组织中促血管生成素-2(Ang-2)、血管内皮生长因子(VEGF)及血管内皮生长因子受体-3(VEGFR-3)的表达。结果Ang-2、VEGF及VEGFR-3在喉鳞癌组织中表达显著高于癌旁正常组织(P均<0.01);Ang-2表达在肿瘤病理分化程度及有无淋巴结转移上差异无统计学意义(P>0.05),VEGF与VEGFR-3的表达在病理分化程度上的比较差异无统计学意义(P>0.05),而有无淋巴结转移上的比较差异有统计学意义(P<0.05);Pearson积差相关性分析:喉鳞癌组织中Ang-2与VEGF的表达呈正相关(r=0.8193,P<0.01);VEGF与VEGFR-3的表达也呈正相关(r=0.7365,P<0.01)。结论Ang-2、VEGF及VEGFR-3与肿瘤的血管生成和成熟密切相关,它们在喉鳞癌组织中的过表达可能在喉鳞癌的发展过程中起重要作用。 Objective To explore the roles and the significances of angiopoietin-2(Ang-2), vascular endothelial growth factor(VEGF)and VEGFR 3 expression and their relationship with clinicopathologic char acteristics of larynx squamous cell carcinoma. Methods Irnmunohistochemical staining was used to detect Ang-2,VEGF and VEGFR-3 expression in larynx squamous eell carcinoma and adjacent normal tissue. Results The expression level of Ang-2, VEGF and VEGFR 3 was significantly higher in larynx squamous cell carcinoma than in adjacent normal tissue(Ang-2, P〈0. 01 ; VEGF, P〈0. 01 ; VEGFR-3, P〈0. 01). There was no significant correlation between Ang-2 expression and tumor differentiation or lymph node metastasis(P〉0. 05). VEGF and VEGFR 3 expression was correlated with lymph node metastasis (P〈0. 05) but not tumor differentiation(P〉0.05). Positive correlation was found between expression of Ang-2 and VEGF(r = 0. 8193, P〈0. 01), also between expression of VEGF and VEGFR-3 (r = 0. 7365,P〈0. 01). Conclusion Expression of Ang-2,VEGF and VEGFR-3 was closely associated with tumor angiogenesis and maturity. Their overexpression may play a major role during the development of larynx squamous cell carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2009年第6期483-486,共4页 Cancer Research on Prevention and Treatment
基金 河北省自然科学基金(C2008000990)
关键词 ANG-2 VEGF VEGFR-3 喉鳞癌 Angiopoietin-2 (Ang-2) Vascular endothelial growth factor(VEGF) VEGFR-3 Larynx Squa- mous Cell Carcinoma
  • 相关文献

参考文献19

  • 1Ogawa M,Yamamoto H. Hepatic expression of Ang-2 RNA in metastatic colorectal cancer[J]. Hepatology, 2004,39 (2):528- 539.
  • 2O'Reilly MS, Holugrem L, Folkman J, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma [ J]. Cell, 1994,79 (2) : 315- 328.
  • 3Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF[J]. Science, 1999,284 (5422) : 1994-1998.
  • 4刘学强,万恒荣,陈海生,彭林.促血管生成素在原位种植肝癌组织中的表达及其意义[J].中国普通外科杂志,2004,13(3):196-198. 被引量:5
  • 5Isner JM,Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for posmalal neovascularization[J]. J Clin Invest, 1999,103(9) : 1231-1236.
  • 6刘舒,王绿娅,郭恒怡,吴其夏.血管生成素的作用机制和功能[J].中华病理学杂志,2003,32(3):273-275. 被引量:7
  • 7Maisonpierre PC,SuriC,Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disruptsin vivoangiogenesis[J]. Science, 1997,277 (5322) : 55-60.
  • 8Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation[J]. Nature, 2000, 407 (6801 ) : 242-248.
  • 9Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis[J]. Science, 1997,277 (5322) : 55 60.
  • 10Stratman A,Risau W,Plate KH. Cell type-specific expression of angiopoietin 1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis[J]. Am J Pathol, 1998,153(5) : 1459-1466.

二级参考文献26

  • 1Li F;Ambrosini G;Chu E Y.Control of apoptosis and mitotic spindle checkpoint by survivin[J],1998(6711).
  • 2Maisonpierre PC;Suri C;Jones PF.Angiopoietin-2,a natural antagonist for Tie2 that disrupts in vivo angiogenesis[J],1997(5322).
  • 3Hattori K;Dias S;Heissig B.Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells[J],2001(9).
  • 4Papapertropoulos A;Fulton D;Mahboubi K.Angiopoietin-1 inhibits endothelial cell apoptosis via Akt/survivin pathway[J],2000(13).
  • 5Kim I;Kim HG;Moon SO.Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion[J],2000.
  • 6Witzenbichler B;Maisonpierre PC;Jones P.Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2[J],1998(29).
  • 7Thurston G;Suri C;Smith K.Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1[J],1999.
  • 8Zagzag D;Hooper A;Friedlander DR.In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis[J],1999.
  • 9Valenzuela DM;Griffiths JA;Rojas J.Angiopoietins 3 and 4: diverging gene counterparts in mice and humans[J],1999(5).
  • 10Marron MB;Hughes DP;Edge MD.Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2[J],2000.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部